Freenome, Inc. Common stock (FRNM)

• Market cap: $1.19B
• 1 day: -7.87%
• 5 days: -3.85%
• 1 month: -13.6%
• 3 months: -13.6%
• 6 months: -13.6%
• Year to date: -13.6%
• 1 year: -13.6%
• 5 years: -13.6%
• 10 years: -13.6%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.